Circulation-Heart Failure

心力衰竭考虑与心力衰竭、机械循环支持和心脏移植科学和医学相关的出版内容，包括在人体中进行的研究或对人体数据的分析，以及与临床直接相关或相关的临床前研究。作为一个主要的临床杂志，很少有基础和临床前研究最终发表。这些将被考虑的是新的，并显著和直接推进心力衰竭领域。编辑们对与心力衰竭直接相关的基础科学研究特别感兴趣，这些研究信息丰富，可转化为人类疾病，并在脊椎动物模型中进行。最终发表的文章不到15%。不直接涉及心力衰竭或心力衰竭治疗的工作将不予考虑，包括在没有心力衰竭底物的情况下研究心肌梗死、再灌注损伤或心律失常的机制。

Circulation Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance. As a primarily clinical journal, few basic and preclinical studies are ultimately published. Those that will be considered are novel, and significantly and directly advance the field of heart failure. The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models. Less than 15% of submitted articles are ultimately published. Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.